Please select the option that best describes you:

What is trastuzumab deruxtecan's activity for patients with CNS+ disease?  

Is there evidence that T-DXd crosses the blood-brain barrier?



Answer from: Medical Oncologist at Academic Institution

Answer from: Medical Oncologist at Academic Institution

Answer from: Medical Oncologist at Community Practice
Comments
Medical Oncologist at Alabama Oncology
In a patient HER2-low disease with intracranial di...
Sign in or Register to read more